WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

M MUSCULO-SKELETAL SYSTEM
M03 MUSCLE RELAXANTS

This group comprises peripherally, centrally and directly acting muscle relaxants.
See also G04BD - Drugs for urinary frequency and incontinence.


M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS

This group comprises peripherally acting muscle relaxants such as curare alkaloids and suxamethonium.
The drugs in this group are mainly used together with anesthetics.

As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.


M03AA Curare alkaloids
M03AB Choline derivatives
M03AC Other quaternary ammonium compounds

Sugammadex indicated for reversal of neuromuscular blockade induced by rocuronium or vecuronium is classified in V03AB - Antidotes.

M03AX Other muscle relaxants, peripherally acting agents

Botulinum toxin used e.g. for treatment of blepharospasm, hemifacial spasm and migraine is classified in this group.

Last updated: 2024-01-26